Farms.com Home   News

Emerson Milling Under New Ownership

Oat processor Emerson Milling Inc. is under new ownership.
 
Real Tetrault started the company 33 years ago. He says the timing was right to sell the business.
 
"It was about a year in the making, where I talked to my accounting firm...we went through almost 100 companies. We sent them a letter telling them Emerson Milling was on sale. We narrowed it down to about five, then to two, then to one. At the end, it's a company out of Winnipeg, it's an investment company, I won't divulge the name at this point, they came up with the best bid."
 
Tetrault says the sale of Emerson Milling was complete on May 11th. He doesn't expect much to change going forward with Jarrod Firlotte taking over as manager.
 
"It was difficult, it's still difficult to talk to staff," Tetrault said. "I enjoyed very much the people we dealt with, and the people we had on staff and the whole Emerson Milling era was great for me and hopefully it was great for the staff as well and great for farmers."
 
Emerson Milling currently employs about 16 to 20 people.
 
Tetrault is now focusing his attention as CEO of Mid Canada Transload Services Ltd. south of Letellier, MB.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.